Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-216-9 | CAS number: 13241-33-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1986
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- publication
- Title:
- Effect of Methyl Hesperidin on Prenatal Development of Rats
- Author:
- Kawashima K, Nakaura S, Usami M, Yamaguchi M, Tanaka S, Takanaka A, Omori Y
- Year:
- 1 986
- Bibliographic source:
- Bulletin of the National Institute of Hygienic Sciences, Tokyo, no. 104, pp. 64-68. 1986.
- Report date:
- 1986
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- not specified
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- (2S)-2-(3,4-dimethoxyphenyl)-5-hydroxy-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one
- Cas Number:
- 11013-97-1
- Molecular formula:
- C29H36O15
- IUPAC Name:
- (2S)-2-(3,4-dimethoxyphenyl)-5-hydroxy-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one
- Test material form:
- solid
Constituent 1
- Specific details on test material used for the study:
- TEST MATERIAL
As for methyl hesperidin, the standardized product according to Japan’s Specification and Standards for Food Addictives (Hamari Chemicals, Lot. No. TO8PG-177) was used.
- Name of test material (as cited in study report): methyl hesperidin
- Molecular formula (if other than submission substance): C29H36O15
- Molecular weight (if other than submission substance): 624.5871
- Smiles notation (if other than submission s.): CC1C(O)C(O)C(O)C(OCC2C(O)C(O)C(O)C(Oc3cc4c(c(O)c3)C(=O)CC(c3ccc(OC)c(OC)c3)O4)O2)O1
- InChl (if other than submission substance): InChI=1S/C29H36O15/c1-11-22(32)24(34)26(36)28(41-11)40-10-20-23(33)25(35)27(37)29(44-20)42-13-7-14(30)21-15(31)9-17(43-19(21)8-13)12-4-5-16(38-2)18(6-12)39-3/h4-8,11,17,20,22-30,32-37H,9-10H2,1-3H3/t11-,17-,20+,22-,23+,24+,25-,26+,27+,28+,29+/m0/s1
- Structural formula attached as image file (if other than submission substance): see Fig. in attached document.
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Japan.
- Age at study initiation: 12-13 weeks
- Weight at study initiation:
- Fasting period before study:
- Housing: All the pregnant rats were accommodated one by one in aluminum cages (Made by Natsume Seisakusho Co., Ltd)
- Diet: solid feed (Oriental Yeast, MF) ad libitum.
- Water: tap water ad libitum.
- Acclimation period:
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 25 ± 2
- Humidity (%): 55± 5
- Air changes (per hr): 15/h
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: Methyl hesperidin was dissolved in distilled water and then given to rats.
- Analytical verification of doses or concentrations:
- not specified
- Details on mating procedure:
- - Impregnation procedure: cohoused
- If cohoused: In order to get pregnant rats, males were arranged to live together with nulliparous females all night, the female rats with sperm recognized in vaginal smear next morning were provided for the test.
- M/F ratio per cage: 1/1
- Length of cohabitation: overnight
- Proof of pregnancy: sperm in vaginal smear referred to as day 0 of pregnancy - Duration of treatment / exposure:
- 10 days
- Frequency of treatment:
- once a day
Doses / concentrationsopen allclose all
- Dose / conc.:
- 8 000 mg/kg bw/day (nominal)
- Remarks:
- 8g/16ml/kg
- Dose / conc.:
- 4 000 mg/kg bw/day (nominal)
- Remarks:
- 4g/8ml/kg
- Dose / conc.:
- 2 000 mg/kg bw/day (nominal)
- Remarks:
- 2g/4ml/kg
- No. of animals per sex per dose:
- 19-20 pregnant rats per group
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: Since the toxicity of methyl hesperidin is extremely low, by considering its solubility and the dosage of its solution against rats, the dosage was set by 3 stages with the highest level as 8 g /16 ml/kg. With a spacing factor of 2, the subsequent doses were 4 g/8ml/kg and 2 g/4ml/kg were respectively set.
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- The general conditions of the pregnant rats were observed, and the body weight and food consumption were measured on a daily base.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily.
BODY WEIGHT: Yes
- Time schedule for examinations:
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Yes
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes
WATER CONSUMPTION AND COMPOUND INTAKE (not a drinking water study): No
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day #20. - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: No data
- Number of late resorptions: No data
- Other: uterus was taken out by cesarean section under anesthesia, and corpora lutea count, implantation count and fetal death were checked. - Fetal examinations:
- Regarding the living fetuses, the exterior abnormalities were searched by hand-touch and visual examination, and the body weights were measured. Around 1/3 of the living fetuses were fixed with Bouin's solution and their internal organs were examined (Wilson method). About 2/3 of the remaining fetuses were fixed with 90% ethanol, stained with alizarin red, and their skeletons were examined with a magnifying glass to check for abnormalities.
- External examinations: Yes:all per litter
- Soft tissue examinations: Yes
- Skeletal examinations: Yes: 2/3 per litter
- Head examinations: Yes - Statistics:
- The results were compared with those of the control group by the X2 test (death rate of maternal rats), t test (body weight, food consumption, corpora lutea count, implantation count, number of fetuses and weight of fetuses) and rank sum test (death rate of fetuses, occurrence rate of morphological abnormality, number of ossification). Statistically significant values had levels of P<0.05 and P<0.01. For the t test, Student's method was used for equal variance, and Aspin-Welch's method was used for unequal variance.
- Indices:
- Death rate of maternal rats, death rate of fetuses, occurrence rate of morphological abnormality, body weight, food consumption, corpora lutea count, implantation count, number of fetuses and weight of fetuses, number of ossification
Results and discussion
Results: maternal animals
General toxicity (maternal animals)
- Clinical signs:
- no effects observed
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- no effects observed
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- no effects observed
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- not examined
- Histopathological findings: neoplastic:
- not examined
- Other effects:
- no effects observed
Maternal developmental toxicity
- Number of abortions:
- effects observed, non-treatment-related
- Description (incidence and severity):
- A maternal rat in which all of the litter had died was found in 4 g / kg group, but there was no significant difference in incidence.
- Pre- and post-implantation loss:
- no effects observed
- Total litter losses by resorption:
- not specified
- Early or late resorptions:
- not specified
- Dead fetuses:
- no effects observed
- Changes in pregnancy duration:
- no effects observed
- Description (incidence and severity):
- Migrated Data from removed field(s)
Field "Effects on pregnancy duration" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsMaternalAnimals.MaternalDevelopmentalToxicity.EffectsOnPregnancyDuration): no effects observed - Changes in number of pregnant:
- no effects observed
- Other effects:
- no effects observed
- Details on maternal toxic effects:
- Maternal toxic effects:yes. Remark: One death animal in the mid-dose group, not considered treatment related
Details on maternal toxic effects:
No change in particular was found in food consumption in all the groups with the dose of methyl hesperidin through the entire dosing period, and the body weight gain was also smooth. No abnormality was recognized in general condition either.
As for the maternal rat with all the litter dead, 1 case was recognized in the group of 4 g/kg, however, no significant difference was recognized in occurrence rate. Regarding to the average corpora lutea count, average implantation count and implantation rate, no significant change was recognized in between the control group and the groups with the dose of methyl hesperidin.
Effect levels (maternal animals)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 8 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Basis for effect level:
- other: maternal and developmental toxicity
Maternal abnormalities
- Key result
- Abnormalities:
- no effects observed
Results (fetuses)
- Fetal body weight changes:
- no effects observed
- Description (incidence and severity):
- Migrated Data from removed field(s)
Field "Fetal/pup body weight changes" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsFetuses.FetalPupBodyWeightChanges): no effects observed - Reduction in number of live offspring:
- no effects observed
- Changes in sex ratio:
- no effects observed
- Changes in litter size and weights:
- no effects observed
- Changes in postnatal survival:
- no effects observed
- External malformations:
- no effects observed
- Skeletal malformations:
- no effects observed
- Description (incidence and severity):
- A skeleton deformity, 1 case (0.7%) of the front vertebra of sacral vertebra was observed out of 27 fetuses in the group of 4g/kg, however, no significant difference was recognized in occurrence rate.
Regarding to the fetuses which have skeletal mutation, 113 cases (79.0%) were observed in the control group, 112 cases (76.0%) were observed in the group of 2g/kg, 132 cases (78.8%) were observed in the group of 4g/kg and 139 cases (79.8%) were observed in the group of 8g/kg. Comparing with the control group, no significant difference was recognized in the occurrence rate of each group with the dose of methyl hesperidin. The types of skeletal mutation observed and their occurrence rates were shown as follows. Cervical rib was observed in each group including the control group by 1.7-3.4%.The deformity of cervical lordosis was observed in the group of 8g/kg by 0.6%, the abnormality of thoracic body (deformity, separation) was observed in each group including the control group by 14.2%-18.6%, however, no significant difference was observed in their occurrence rate. In addition, the abnormality of sternebra (deformity, separation and damage) was observed by 43.2%-61.2% in each group including the control group. Lumbar rib (including rudimentary rib) was observed in each group including the control group by 31.0%-42.0%. However, no significant difference was recognized in its occurrence rate. - Visceral malformations:
- effects observed, non-treatment-related
- Description (incidence and severity):
- The cases of dilatation of renal pelvis were observed in each group including the control group by 1.7-4.9%, however, no significant difference was recognized in occurrence rate.
- Other effects:
- no effects observed
- Details on embryotoxic / teratogenic effects:
- No significant change was recognized in between the control group and the groups with the dose of methyl hesperidin in average number of fetuses, sex ratio, and average body weight of fetuses. No abnormal case was observed including the control group in results of visual test. Ossification status was judged by checking the number of metatarsal bones, sacral vertebrae and caudal vertebra, however, no significant difference was recognized from the control group regarding to all of these.
Effect levels (fetuses)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 8 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no significant effects observed at any dose level.
Fetal abnormalities
- Key result
- Abnormalities:
- no effects observed
Overall developmental toxicity
- Key result
- Developmental effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- The test item was found to be non-teratogenic under test conditions, with a NOAEL of 8000 mg/kg bw/d for both maternal and developmental toxicity.
- Executive summary:
A prenatal developmental toxicity test was conducted by a method similar to OECD 414. Daily oral administration of the test item to 19 -20 Wistar rats per group at doses of 2, 4 and 8 g/kg, from the 7th day of pregnancy to the 17th of pregnancy was performed. A control group receiving 16 ml/kg distilled water was run in parallel. No changes in death rate, food consumption or body weight gain were observed for any of the treated groups. There was no significant change in mean fetal number, sex ratio and fetal mortality in any of the treated fetuses, no abnormalities related to the test item were observed. Based on the results, the NOAEL for maternal and developmental toxicity in rats was set at 8000 mg/kg bw. The test item was not teratogenic under test conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.